ZALEWSKI, Jakub Zbigniew et al. How does the use of GLP-1 receptor agonists affect bone mineral density and fracture risk in obese individuals?. Journal of Education, Health and Sport, [S. l.], v. 87, p. 68397, 2026. DOI: 10.12775/JEHS.2026.87.68397. Disponível em: https://apcz.umk.pl/JEHS/article/view/68397. Acesso em: 5 feb. 2026.